SCHEMBL27918656

SCHEMBL27918656

CC(O)c1cccc(F)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 1/20 0.39
NFKB1 P19838 1/20 0.39
PNMT P11086 1/20 0.39
LMNA P02545 2/20 0.38
ALDH1A1 P00352 1/20 0.38
GLA P06280 1/20 0.38
P2RX7 Q99572 1/20 0.38
PDE2A O00408 1/20 0.38
CES2 O00748 3/20 0.37
CES1 P23141 3/20 0.37
GABRA1 P14867 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
HTR2C P28335 2/20 0.37
FAAH O00519 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31521437 0.86 PDE2A (0.41) CYP3A4CYP1A2CYP2D6NFKB1PNMT
SCHEMBL9967747 0.83 GABRA1 (0.44) CYP3A4CYP1A2CYP2D6NFKB1PNMT
SCHEMBL28758952 0.79 CYP3A4 (0.39) CYP3A4CYP1A2CYP2D6NFKB1PNMT
SCHEMBL16953380 0.79 CYP1A2 (0.39) CYP3A4CYP1A2CYP2D6NFKB1PNMT
SCHEMBL17553331 0.79 CYP3A4 (0.39) CYP3A4CYP1A2CYP2D6NFKB1PNMT
SCHEMBL24039916 0.79 CYP1A2 (0.39) CYP3A4CYP1A2CYP2D6NFKB1PNMT
SCHEMBL30202466 0.79 PNMT (0.64) CYP3A4CYP1A2CYP2D6NFKB1PNMT
SCHEMBL14121111 0.79 PNMT (0.64) CYP3A4CYP1A2CYP2D6NFKB1PNMT
SCHEMBL28361634 0.79 CYP3A4 (0.39) CYP3A4CYP1A2CYP2D6NFKB1PNMT
SCHEMBL25665348 0.79 CES2 (0.37) CYP3A4CYP1A2LMNACES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096957-A1 RAS-PI3K INHIBITORS AND USES THEREOF VIVIDION THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
CN-107794282-A A kind of gram of azoles replaces the preparation method and bacterial strain of Buddhist nun's chiral intermediate 浙江工业大学 2018-03-13 CN disclosed
CN-103319311-A Preparation method of crizotinib intermediate (1S)-1-(2, 6-dichloro-3-fluorophenyl)ethanol ZHEJIANG JIUZHOU PHARMACEUTICAL TECHNOLOGY CO LTD 2013-09-25 CN disclosed